Package 50090-7602-0

Brand: bupropion hydrochloride xl

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 50090-7602-0
Digits Only 5009076020
Product NDC 50090-7602
Product ID 50090-7602_a82adea5-b3bd-4c8b-9ae5-86e16684ec71
Description

90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7602-0)

Marketing

Marketing Status
Marketed Since 2025-07-14
Brand bupropion hydrochloride xl
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Bupropion Hydrochloride XL ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "a82adea5-b3bd-4c8b-9ae5-86e16684ec71", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["eee88553-acff-4bdd-acd1-f39bcb6fcdca"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7602-0)", "package_ndc": "50090-7602-0", "marketing_start_date": "20250714"}], "brand_name": "Bupropion Hydrochloride XL", "product_id": "50090-7602_a82adea5-b3bd-4c8b-9ae5-86e16684ec71", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "50090-7602", "generic_name": "Bupropion Hydrochloride", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "XL", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA090693", "marketing_category": "ANDA", "marketing_start_date": "20170614", "listing_expiration_date": "20261231"}